Skip to main content

Diagnostic options Β· UAE

Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 46–60 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3777
CFHR1 Gene Hemolytic Uremic Syndrome Genetic Test

This test evaluates the CFHR1 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It identifies deletions, duplications, and point mutations wit...

Whole blood, buccal swab, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CFHR1 gene variants (deletions, duplications, point mutations)", "Copy Number Variations (CNV) in the CFHR1 gene"]
Parameters
[{"name": "CFHR1 Gene Analysis", "reference_range": "Negative for pathogenic variants"}]
Preparation
["No fasting required.", "No medication changes required."]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Familial risk stratification for aHUS", "Personalised treatment planning for aHUS", "Cascade screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-2 ICD-10: D59.3
Clinical summary
This test evaluates the CFHR1 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It identifies deletions, duplications, and point mutations within the gene.
TEST-3810
CFHR4 Gene Hemolytic Uremic Syndrome (HUS) Genetic Test

This test evaluates the CFHR4 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS).

Whole blood, extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CFHR4 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Family screening for CFHR4 variants", "Evaluation of patients with suspected complement-mediated disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81329-5 ICD-10: D59.32
Clinical summary
This test evaluates the CFHR4 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS).
TEST-3806
CFI Gene Hemolytic Uremic Syndrome (HUS) Genetic Test

This test evaluates the entire coding region of the CFI gene for pathogenic variants associated with complement-mediated atypical hemolytic uremic syndrome (aHUS).

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CFI gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["Pre-genetic counselling is mandatory.", "Document a three-generation pedigree."]
Indications
["Suspected atypical hemolytic uremic syndrome (aHUS)", "Family history of aHUS", "Need for genetic predisposition assessment for lifelong management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D59.32
Clinical summary
This test evaluates the entire coding region of the CFI gene for pathogenic variants associated with complement-mediated atypical hemolytic uremic syndrome (aHUS).
TEST-3468
CFTR Gene Congenital Bilateral Absence of Vas Deferens (CBAVD) NGS Test

This diagnostic test evaluates the CFTR gene for pathogenic variants associated with congenital bilateral absence of the vas deferens (CBAVD), a common cause of male infertility.

Blood or Extracted DNA (Peripheral Whole Blood) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CFTR gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of CBAVD", "Evaluation of male infertility", "Genetic counseling for reproductive options"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21656-1 ICD-10: Q55.4
Clinical summary
This diagnostic test evaluates the CFTR gene for pathogenic variants associated with congenital bilateral absence of the vas deferens (CBAVD), a common cause of male infertility.
TEST-5313
CHRND Gene Sequencing for Congenital Myasthenic Syndrome Type 3C Test

This test identifies pathogenic variants in the CHRND gene associated with Congenital Myasthenic Syndrome Type 3C.

Whole Blood (EDTA/ACD), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CHRND gene coding region variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid strenuous activity before sample collection"]
Indications
["Suspected Congenital Myasthenic Syndrome Type 3C", "Family history of CMS", "Failure to respond to standard CMS treatments"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86635-0 ICD-10: G70.2, Z15.09, Z13.79
Clinical summary
This test identifies pathogenic variants in the CHRND gene associated with Congenital Myasthenic Syndrome Type 3C.
TEST-4661
CHST8 Gene Peeling Skin Syndrome Type 3 Genetic Test

This genetic test identifies pathogenic variants in the CHST8 gene associated with acral peeling skin syndrome type 3.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CHST8 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Select Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting or special preparation required before the blood draw."]
Indications
["Clinical suspicion of acral peeling skin syndrome type 3", "Family history of peeling skin syndrome", "Carrier screening for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93957-3 ICD-10: Q82.8
Clinical summary
This genetic test identifies pathogenic variants in the CHST8 gene associated with acral peeling skin syndrome type 3.
TEST-4040
CIZ1 Gene Analysis for Cervical Dystonia Test

This test analyzes the CIZ1 gene for mutations associated with cervical dystonia, a movement disorder causing involuntary neck muscle contractions.

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 21–28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["CIZ1 gene variants", "Single nucleotide variants", "Insertions", "Deletions", "Deep intronic variants"]
Parameters
[]
Preparation
[]
Indications
["Confirm clinical diagnosis of cervical dystonia", "Differentiate from other neurological movement disorders", "Guide family planning", "Recurrence risk counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G24.3
Clinical summary
This test analyzes the CIZ1 gene for mutations associated with cervical dystonia, a movement disorder causing involuntary neck muscle contractions.
TEST-6179
CLN3 Gene Ceroid Lipofuscinosis Neuronal Type 3 Genetic Test

This test identifies pathogenic variants in the CLN3 gene associated with juvenile-onset neuronal ceroid lipofuscinosis (Batten disease). It utilizes Next-Generation Sequencing (NG...

Peripheral Whole Blood (3 mL in EDTA tube) 3–4 Weeks (expedited option available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CLN3 gene", "Copy Number Variants (CNVs) within the CLN3 gene"]
Parameters
[]
Preparation
["No fasting required", "No medication changes needed", "Provide detailed medical history", "Complete informed consent form"]
Indications
["Suspected diagnosis of juvenile-onset Batten disease (NCL3)", "Family history of Batten disease", "Confirmation of clinical diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82329-8 ICD-10: E75.4
Clinical summary
This test identifies pathogenic variants in the CLN3 gene associated with juvenile-onset neuronal ceroid lipofuscinosis (Batten disease). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-6276
COG1 Gene Glycosylation Disorder Type 2G (COG1-CDG) Genetic Test

This test identifies pathogenic variants in the COG1 gene to diagnose Congenital Disorder of Glycosylation Type IIg (COG1-CDG).

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COG1 gene", "Presence of mutations causing COG1-CDG"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Suspected COG1-CDG based on clinical presentation", "Family history of COG1-CDG", "Carrier screening for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92807-0 ICD-10: E77.8
Clinical summary
This test identifies pathogenic variants in the COG1 gene to diagnose Congenital Disorder of Glycosylation Type IIg (COG1-CDG).
TEST-2286
COL2A1 Gene Spondyloepimetaphyseal Dysplasia Strudwick Type NGS Test

This diagnostic test evaluates the entire coding region of the COL2A1 gene for pathogenic variants associated with Spondyloepimetaphyseal Dysplasia Strudwick type.

Peripheral whole blood (3–5 mL in EDTA tube), extracted genomic DNA, or dried blood spot on FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL2A1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required", "Genetic counselling session and pedigree charting are mandatory before testing"]
Indications
["Diagnosis of Spondyloepimetaphyseal Dysplasia Strudwick type", "Carrier status determination", "Prenatal confirmation under genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q77.7
Clinical summary
This diagnostic test evaluates the entire coding region of the COL2A1 gene for pathogenic variants associated with Spondyloepimetaphyseal Dysplasia Strudwick type.
TEST-5747
COL4A3 Gene Alport Syndrome (Autosomal Recessive) Test

This test evaluates the COL4A3 gene for mutations associated with autosomal recessive Alport syndrome.

Whole Blood (EDTA tube), Extracted DNA, or One Drop Blood on FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic single-nucleotide variants in COL4A3", "Small insertions/deletions in COL4A3", "Copy-number alterations in COL4A3"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed unless advised by physician"]
Indications
["Suspected Alport syndrome", "Family history of Alport syndrome", "Evaluation of hematuria with hearing loss or eye abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 20851-7 ICD-10: Q87.81
Clinical summary
This test evaluates the COL4A3 gene for mutations associated with autosomal recessive Alport syndrome.
TEST-5118
COX4I2 Gene Genetic Test

This test evaluates the entire coding region and splice sites of the COX4I2 gene for pathogenic variants.

Peripheral whole blood (3–5 mL in EDTA) or buccal swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COX4I2 gene", "Coding region and splice site variants"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"]
Indications
["Suspected COX4I2-related disorder", "Family history of the associated syndrome", "Evaluation of unexplained pancreatic insufficiency, anemia, and bone abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q87.8, D61.09, K86.81, M85.2
Clinical summary
This test evaluates the entire coding region and splice sites of the COX4I2 gene for pathogenic variants.
TEST-5067
COX6B1 Gene Mitochondrial Complex IV Deficiency Genetic Test

This genetic test evaluates the COX6B1 gene for pathogenic variants associated with mitochondrial complex IV deficiency.

Whole blood (EDTA) or buccal swab 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COX6B1 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Suspected mitochondrial complex IV deficiency", "Neurological disorders of unknown origin", "Family history of mitochondrial disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81395-7 ICD-10: E88.49
Clinical summary
This genetic test evaluates the COX6B1 gene for pathogenic variants associated with mitochondrial complex IV deficiency.
TEST-6184
CPOX Gene Coproporphyria Genetic Test

This test evaluates the CPOX gene for pathogenic variants associated with Hereditary Coproporphyria (HCP).

Peripheral Whole Blood or Dried Blood Spot (DBS) 14–21 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CPOX gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform physician about all medications"]
Indications
["Suspicion of Hereditary Coproporphyria (HCP)", "Family history of porphyria", "Need for genetic counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E80.2
Clinical summary
This test evaluates the CPOX gene for pathogenic variants associated with Hereditary Coproporphyria (HCP).
TEST-4218
CR1 Gene Deficiency Genetic Test

This test detects pathogenic variants in the CR1 gene, identifying individuals with complement receptor 1 deficiency.

Peripheral Whole Blood, Extracted DNA, or FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CR1 gene", "Carrier status for complement receptor 1 deficiency"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Guardian consent required for minors"]
Indications
["Patients with a family history of SLE", "Individuals with recurrent infections", "Suspected complement deficiency based on abnormal CH50 levels"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-3 ICD-10: D84.1
Clinical summary
This test detects pathogenic variants in the CR1 gene, identifying individuals with complement receptor 1 deficiency.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requiresβ€”book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.